Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0P5CM
|
||||
| Former ID |
DIB006751
|
||||
| Drug Name |
AZD-3161
|
||||
| Indication | Peripheral neuropathy [ICD10:G64] | Phase 1 | [549173] | ||
| Company |
AstraZeneca plc
|
||||
| Target and Pathway | |||||
| Target(s) | Sodium channel | Target Info | Modulator | [551649] | |
| KEGG Pathway | Dopaminergic synapse | ||||
| Reactome | Interaction between L1 and Ankyrins | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.